<?xml version="1.0" encoding="UTF-8"?>
<p>An important feature of this Research Topic collection, many well-known scholars have contributed a lot of wonderful literature reviews about medicinal plants for aging-related cardiovascular and neurodegenerative diseases. 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00699" xmlns:xlink="http://www.w3.org/1999/xlink">Souza-Junior et al.</ext-link> discuss the ethnobotanical characteristics, phytochemical constitution, and cardiovascular and neurological properties of 
 <italic>A. canelilla</italic>, systematizing the knowledge about the species and proposing new perspectives for research and development. 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00422" xmlns:xlink="http://www.w3.org/1999/xlink">Shaito et al.</ext-link> overview the data on the ethnopharmacological therapeutic potentials and medicinal properties against CVDs (myocardial infarction, hypertension, peripheral vascular diseases, coronary heart disease, cardiomyopathies, and dyslipidemias) of 
 <italic>Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum</italic>. 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00852" xmlns:xlink="http://www.w3.org/1999/xlink">Michel et al.</ext-link> reviewed the potential use of medicinal plants from Asteraceae and Lamiaceae Plant Family in CVDs. Atherosclerosis is the main pathological mechanism of aging-related cardiovascular and neurodegenerative diseases, characterized by changes of blood lipids profile and inflammation in vessel wall. 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00403" xmlns:xlink="http://www.w3.org/1999/xlink">Kirichenko et al.</ext-link> reviewed the databases PubMed and Scopus (until November, 2019) to investigate the medicinal plants possessing anti-atherosclerotic activity in experimental and clinical studies. 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00118" xmlns:xlink="http://www.w3.org/1999/xlink">WuÂ M. et al.</ext-link> summarize the blood lipid lowering, anti-oxidative, anti-inflammatory, and vascular endothelial protection by hawthorn and its extracts, providing a potential use for atherosclerosis. This Research Topic also includes a systematic preclinical review of the effect of Notoginsenoside R1 (NGR1) for ischemia/reperfusion injury. The study by 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2019.01204" xmlns:xlink="http://www.w3.org/1999/xlink">Tong et al.</ext-link> showed the organ protection effect of NGR1 after I/R injury, suggesting that NGR1 can potentially become a novel drug candidate for ischemic diseases.
</p>
